Business

February 4, 2014

Furiex shares jump 130% on positive drug trial results

Shares of Furiex Pharmaceuticals surged 130 percent after the Morrisville drug development company reported positive test results for its irritble bowel syndrome treatment.

Related content

Comments

Videos

Editor's Choice Videos